These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8616506)

  • 1. Estimation of central activity of hydroxyproline--the amino acid characteristic for collagen degradation products.
    Wiśniewski K; Lutostańska A; Artemowicz B; Maćkowiak J
    Pol J Pharmacol; 1995; 47(4):285-91. PubMed ID: 8616506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A search for new active amino acids responsible for pharmacological activity of collagen degradation products.
    Lutostańska A; Telejko E; Maćkowiak J; Wiśniewski K
    Pol J Pharmacol; 1993; 45(3):253-68. PubMed ID: 8220659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of collagen degradation products (CDP) on the central nervous system (CNS).
    Telejko E; Maćkowiak J; Ksiazek J; Wiśniewski K
    Rocz Akad Med Bialymst (1989); 1992; 37():8-17. PubMed ID: 1337476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central activity of peptide Gly-Pro-Hyp--the main component of collagen degradation products mixture.
    Wiśniewski K; Artemowicz B; Lutostańska A; Maćkowiak J; Koziołkiewicz W
    Acta Neurobiol Exp (Wars); 1994; 54(1):33-8. PubMed ID: 8023712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solcoseryl stimulates behavioural activity of rats.
    Braszko JJ; Winnicka MM; Wiśniewski K
    Acta Physiol Hung; 1996; 84(1):63-72. PubMed ID: 8993676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of albumin degradation products on central action of amphetamine and pentetrazol.
    Sobaniec W; Moniuszko-Jakoniuk J; Zarebski M; Buczko W; Tarasiewicz S
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):531-6. PubMed ID: 999469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of collagen degradation products (CDP) on the central dopaminergic system.
    Telejko E; Maćkowiak J; Wiśniewski K
    Acta Physiol Pol; 1990; 41(7):127-37. PubMed ID: 2136307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of albumin degradation products on central effect of thiopental.
    Sobaniec W; Moniuszko-Jakoniuk J; Zarebski M
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):525-30. PubMed ID: 999468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae).
    de Oliveira L; Cunha AO; Mortari MR; Coimbra NC; Dos Santos WF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):198-203. PubMed ID: 16310919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of Hemidesmus indicus and its active principle 2-hydroxy 4-methoxy benzoic acid on ethanol-induced liver injury.
    Saravanan N; Nalini N
    Fundam Clin Pharmacol; 2007 Oct; 21(5):507-14. PubMed ID: 17868203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
    Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewska RJ; Wiśniewski K
    Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of albumin degradation products (ADP) on the central action of catecholamines.
    Tarasiewicz S; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats.
    Browman KE; Badiani A; Robinson TE
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1007-14. PubMed ID: 9864286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mercuric chloride on urinary excretion of free hydroxyproline.
    Siddiqi NJ; Alhomida AS
    Med Sci Monit; 2006 Mar; 12(3):BR95-101. PubMed ID: 16501418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of kainic acid-induced seizures on sleep patterns.
    Ayala-Guerrero F; Alfaro A; Martínez C; Campos-Sepúlveda E; Vargas L; Mexicano G
    Proc West Pharmacol Soc; 2002; 45():178-80. PubMed ID: 12434574
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological and pharmacological effects of D-arginine.
    Navarro E; Alonso SJ; Martín FA; Castellano MA
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):149-54. PubMed ID: 16128908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.